Results 101 to 110 of about 3,163 (211)

The effects on Hemostasis of Oral Contraceptives Containing Desogestrel

open access: yes, 1993
Epidemiologic research has shown that current low-dose estrogen oral contraceptives are associated with a low risk of vascular events (e.g., myocardial infarction, stroke, and venous thrombosis or thromboembolism).
Stubblefield, P G
core   +1 more source

PREVENTION WITH DESORGESTREL OF ENDOMETRIOUS CYSTS RECURRENCE AFTER SURGICAL TREATMENT

open access: yesJournal of Experimental and Molecular Biology, 2018
Currently, endometriosis is an important public health issue due to the increasing number of cases and the risk of developing ovarian and endometrial tumours(10% of ovarian endometrial carcinomas are associated with uterine endometrioid carcinomas ...
Eduard Crauciuc   +4 more
doaj  

Hormone withdrawal-associated symptoms with ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 µg/desogestrel 150 µg (21/7 regimen)

open access: yesInternational Journal of Women's Health, 2015
Johannes Bitzer,1 Maria Jesusa Banal-Silao,2 Hans-Joachim Ahrendt,3 Jaime Restrepo,4 Marion Hardtke,5 Ulrike Wissinger-Graefenhahn,6 Dietmar Trummer7 1Department of Obstetrics and Gynecology, University Hospital of Basel, Basel, Switzerland; 2University ...
Bitzer J   +6 more
doaj  

Revista Brasileira de Ginecologia e Obstetrícia

open access: yes, 1998
Realizou-se um estudo aberto comparativo em nove centros brasileiros para avaliar a tolerabilidade e o controle de ciclo obtido com o uso de dois contraceptivos orais de baixa dose contendo 20 mg etinilestradiol/75 mg gestodeno e 20 mg etinilestradiol ...
Hyppolito, Sylvia B.   +8 more
core  

The effects of ethinyl estradiol and desogestrel on the rat ovary: I. histological changes

open access: yes, 1995
Yüksek dozda 5-10-15-20-25-30 gün ve düşük dozda 5-10-15-20-25-30-35-40-45-70 gün süreyle mide sondası ile ethinyl estradiol (EE) + desogestrel verilen sıçanlarda ovaryumlar ışık mikroskobik olarak incelendi. Yapılan incelemelerde öncelikle folliküler ve

core  

Food and Drug Administration

open access: yes, 2007
Public Citizen, representing more than 100,000 consumers nationwide, hereby petitlons the Food and Drug Administration (FDA) pursuant to the Federal Food, Drug and Cosmetic Act 21 U.S.C. Section 355(e)(3), and 21 C.F.R.
Andrew Von Eschenbach   +1 more
core  

Therapeutical approaches in Congenital Central Hypoventilation Syndrome (CCHS): the case of the progestin Desogestrel

open access: yes, 2016
Congenital Central Hypoventilation Syndrome (CCHS, MIM 209880) is a rare neonatal disease characterized by abnormal ventilatory response to hypoxia and hypercapnia, owing to failure of autonomic respiratory control.
R Benfante   +4 more
core  

Home - About - Disclaimer - Privacy